Your browser doesn't support javascript.
loading
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Hui, Rina; Özgüroglu, Mustafa; Villegas, Augusto; Daniel, Davey; Vicente, David; Murakami, Shuji; Yokoi, Takashi; Chiappori, Alberto; Lee, Ki Hyeong; de Wit, Maike; Cho, Byoung Chul; Gray, Jhanelle E; Rydén, Anna; Viviers, Louis; Poole, Lynne; Zhang, Yiduo; Dennis, Phillip A; Antonia, Scott J.
Afiliação
  • Hui R; Department of Medical Oncology, Westmead Hospital and the University of Sydney, Sydney, NSW, Australia. Electronic address: rina.hui@sydney.edu.au.
  • Özgüroglu M; Division of Medical Oncology, Department of Internal Medicine, Cerrahpasa School of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.
  • Villegas A; Cancer Specialists of North Florida, Jacksonville, FL, USA.
  • Daniel D; Sarah Cannon Research Institute, Nashville and Tennessee Oncology, Chattanooga, TN, USA.
  • Vicente D; Department of Medical Oncology, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Murakami S; Department of Thoracic Oncology, Kanagawa Cancer Centre, Kanagawa, Japan.
  • Yokoi T; Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Japan.
  • Chiappori A; Thoracic Oncology Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Lee KH; Department of Internal Medicine, College of Medicine, Chungbuk National University Hospital, Cheongju, Korea.
  • de Wit M; Department of Internal Medicine-Hematology, Oncology and Palliative Medicine, Vivantes Klinikum Neukölln, Berlin, Germany.
  • Cho BC; Department of Internal Medicine, Yonsei Cancer Centre, Yonsei University College of Medicine, Seoul, South Korea.
  • Gray JE; Thoracic Oncology Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Rydén A; AstraZeneca, Gothenburg, Sweden.
  • Viviers L; IQVIA, Saint-Ouen, France.
  • Poole L; AstraZeneca, Cambridge, UK.
  • Zhang Y; AstraZeneca, Gaithersburg, MD, USA.
  • Dennis PA; AstraZeneca, Gaithersburg, MD, USA.
  • Antonia SJ; Thoracic Oncology Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Lancet Oncol ; 20(12): 1670-1680, 2019 12.
Article em En | MEDLINE | ID: mdl-31601496
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Quimiorradioterapia / Medidas de Resultados Relatados pelo Paciente / Antineoplásicos Imunológicos / Neoplasias Pulmonares / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Quimiorradioterapia / Medidas de Resultados Relatados pelo Paciente / Antineoplásicos Imunológicos / Neoplasias Pulmonares / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article